AzTrials
AzTrials

Blood PressureNCT01359748

Clinical Study About Blood Pressure Measurement Efficacy on Multifunction KEITO

A study testing Reference sphygmomanometer and Sphygmomanometer under test in people with Blood Pressure, run by Aguiflai Iberica, S.L..

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this trial is to determine the accuracy of the Blood Pressure (BP) measurement of multifunction KEITO devices under test requirements of the Standard American National Standards Institute(ANSI)/Association for the Advancement of Medical Instrumentation(AAMI)/International Organization for… Read more about this study

Who is it for?
Ages 18 to 83 yearsHealthy volunteers can take part
Conditions the study is for
Blood Pressure
What is being tested?
Reference sphygmomanometer and Sphygmomanometer under test
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
89 participants
Where
No sites listed yet
Study dates
Mar 2011to Mar 2011
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 83 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Wrist circumference: 12 to 20 Cm
  • At least 5% of the readings shall have Systolic BP<=100 mmHg
  • At least 5% of the readings shall have Systolic BP>=160 mmHg
  • At least 20% of the readings shall have Systolic BP>=140 mmHg
  • At least 5% of the readings shall have Diastolic BP<=60 mmHg
  • At least 5% of the readings shall have Diastolic BP>=100 mmHg
  • At least 20% of the readings shall have Diastolic BP>=85 mmHg

Who cannot join

  • Pregnant Women

About this study

The purpose of this trial is to determine the accuracy of the Blood Pressure (BP) measurement of multifunction KEITO devices under test requirements of the Standard American National Standards Institute(ANSI)/Association for the Advancement of Medical Instrumentation(AAMI)/International Organization for Standardization (ISO): ANSI/AAMI/ISO 81060-2:2009.

Read the detailed description

Nowadays is important controlling our basic health parameters. Due this, the multifunction KEITO Devices was designed to offer to the general public a convenient way to do so easily in the public sites.

One of the most important parameter is the Blood Pressure (BP)measurement. To warrant their efficacity and accuracy, was essential to perform this trial to ensure that the measurements obtained meet with the requirements of the specific U.S. standard about Non-invasive sphygmomanometers.

By Validating with auscultatory reference sphygmomanometer, as defined on the ANSI/AAMI/ISO 81060-2:2009 , we have been intending to demonstrate that the multifunction KEITO devices, particularly about the Blood Pressure (BP) Measurement, have the same efficacy and accuracy as the conventional auscultatory sphygmomanometers.

To include most of the groups of Blood Pressure (BP) measurements types on this clinical trial, a great variety of BP ranges have been selected, always in accordance with the standard.

Conditions
Blood Pressure
Being tested
Reference sphygmomanometer, Sphygmomanometer under test
Keywords
Non Invasive Blood Pressure measurement study.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reference sphygmomanometerDevice

    Also called *Ref Auscult. sphygm.: RIESTER MINIMUS S/N 20534567

    • USED Audible Korotkoff (K5)for Auscultatory sphygmomanometer.
  • Sphygmomanometer under testDevice

    Also called * Multifunction KEITO K7 S/N 1941.

    Electronic Oscillometric method.

Study groups in NCT01359748
Study groupRoleWhat they receive
Wrist Size <= 14.25 CmOther* Blood pressure measured using the reference sphygmomanometer. * Blood pressure measured using the Sphygmomanometer under test.
Receives: Device: Reference sphygmomanometer; Device: Sphygmomanometer under test
Wrist Size >=14.26 <16.50 CmOther* Blood pressure measured using the reference sphygmomanometer. * Blood pressure measured using the Sphygmomanometer under test.
Receives: Device: Reference sphygmomanometer; Device: Sphygmomanometer under test
Wrist size >=16.5 <17.75 CmOther* Blood pressure measured using the reference sphygmomanometer. * Blood pressure measured using the Sphygmomanometer under test.
Receives: Device: Reference sphygmomanometer; Device: Sphygmomanometer under test
Wrist Size >=17.75 CmOther* Blood pressure measured using the reference sphygmomanometer. * Blood pressure measured using the Sphygmomanometer under test.
Receives: Device: Reference sphygmomanometer; Device: Sphygmomanometer under test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. BP Measurements Using the Reference Auscultatory Sphygmomanometer

    The subject was measured by the two observers at the same time using the reference sphygmomanometer and double stethoscope.

    The observers agree to take the K5 korotkoff sound. Each observer takes notes of their own measures.

    Measured: Five minutes

  2. BP Measurement Using Multifunction KEITO

    Prior starting the measurement phase using Multifunction KEITO, the under test device was reset before each new measurement.

    The subject has to be at rest at least 60 seconds before be measured.

    Measured: 30 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 May 2011 (estimated)
  2. Study startMar 2011
  3. Primary completionMar 2011
  4. Study completionMar 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Non-randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
89 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01359748
Sponsor's protocol ID
K8-BP-31032011
Status last verified
Jul 2014
First submitted
16 May 2011
Last updated
29 Jul 2014
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Reference sphygmomanometer and Sphygmomanometer under test in people with Blood Pressure, run by Aguiflai Iberica, S.L..

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jul 2014. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 7 Nov 2013). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

BP Measurements Using the Reference Auscultatory Sphygmomanometer (time frame: Five minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in